Working… Menu

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB (STREAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02409290
Recruitment Status : Recruiting
First Posted : April 6, 2015
Last Update Posted : March 12, 2019
Medical Research Council
Institute of Tropical Medicine, Belgium
London School of Hygiene and Tropical Medicine
Rede TB
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : June 2022
Publications of Results:
Other Publications:

Publications automatically indexed to this study by Identifier (NCT Number):